Fiscal Year 2013 Work Plan Highlights OIG’s Medicare Parts C and D Priorities
Written by Theresa C. Carnegie, Tara E. Swenson, and Roy M. Albert
Last week, the OIG published its FY 2013 Work Plan. The Work Plan summarizes new and ongoing reviews and activities that the OIG plans to pursue with respect to HHS programs and operations during FY 2013 and beyond, and includes several initiatives related to Medicare Advantage and Medicare Part D that will be of interest to Medicare Advantage Organizations (MAOs), Part D plan sponsors, pharmaceutical manufacturers, PBMs, and pharmacies. Many of the areas identified will result in the OIG reviewing the conduct of and oversight by MAOs, plan sponsors, and CMS.
Read the full advisory.
Authors
M. Daria Niewenhous
Member Emerita
Theresa C. Carnegie
Member
Theresa advises clients on all aspects of the pharmaceutical supply chain, including counseling industry stakeholders on a range of business, legal, transactional, and compliance matters. She provides clients with strategic counseling and creative business modeling that considers legal restrictions and regulatory risk in light of innovation and business goals.